共 50 条
- [41] Identifying the Semantics of Eligibility Criteria of Clinical Trials based on relevant Medical OntologiesIEEE 12TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS & BIOENGINEERING, 2012, : 413 - 421Bucur, Anca论文数: 0 引用数: 0 h-index: 0机构: Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, Netherlands Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, Netherlandsvan Leeuwen, Jasper论文数: 0 引用数: 0 h-index: 0机构: Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, Netherlands Univ Politecn Madrid, Fac Informat, Dept Inteligenc Artificial, Grp Informat Biomed, Madrid, Spain Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, NetherlandsPerez-Rey, David论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Madrid, Fac Informat, Dept Inteligenc Artificial, Grp Informat Biomed, Madrid, Spain Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, NetherlandsAlonso Calvo, Raul论文数: 0 引用数: 0 h-index: 0机构: Univ Politecn Madrid, Fac Informat, Dept Inteligenc Artificial, Grp Informat Biomed, Madrid, Spain Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, NetherlandsClaerhout, Brecht论文数: 0 引用数: 0 h-index: 0机构: Custodix NV, Sint Martens Latem, Belgium Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, Netherlandsde Schepper, Kristof论文数: 0 引用数: 0 h-index: 0机构: Custodix NV, Sint Martens Latem, Belgium Healthcare Informat Management Philips Res Europe, High Tech Campus 34, Eindhoven, Netherlands
- [42] Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical TrialsJNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (11): : 1437 - 1440Denicoff, Andrea M.论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USAIvy, S. Percy论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USATamashiro, Tami T.论文数: 0 引用数: 0 h-index: 0机构: Emmes, Rockville, MD USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USAZhao, Jinxiu论文数: 0 引用数: 0 h-index: 0机构: Emmes, Rockville, MD USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USAWorthington, Katherine H.论文数: 0 引用数: 0 h-index: 0机构: Emmes, Rockville, MD USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USAMooney, Margaret M.论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USALittle, Richard F.论文数: 0 引用数: 0 h-index: 0机构: NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USA NCI, Div Canc Treatment & Diag, Canc Therapy Evaluat Program, 9609 Med Ctr Dr,Rm 5W428,MSC 9737, Bethesda, MD 20892 USA
- [43] Eligibility criteria in haematological cancer clinical trials-what's needed?LANCET HAEMATOLOGY, 2020, 7 (01): : E10 - E10Calissano, Mattia论文数: 0 引用数: 0 h-index: 0机构: Med & Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London E14 4PU, England Med & Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London E14 4PU, EnglandPanico, Maria Beatrice论文数: 0 引用数: 0 h-index: 0机构: Med & Healthcare Prod Regulatory Agcy, Clin Trials Unit, London E14 4PU, England Med & Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London E14 4PU, EnglandO'Connor, Daniel J.论文数: 0 引用数: 0 h-index: 0机构: Med & Healthcare Prod Regulatory Agcy, Licencing Div, London E14 4PU, England Med & Healthcare Prod Regulatory Agcy, Vigilance & Risk Management Med, London E14 4PU, England
- [44] Eligibility criteria perpetuate disparities in enrollment and participation in pancreatic cancer clinical trialsCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)Riner, Andrea N.论文数: 0 引用数: 0 h-index: 0Girma, Selamawit论文数: 0 引用数: 0 h-index: 0Skoro, Nevena论文数: 0 引用数: 0 h-index: 0Gal, Tamas S.论文数: 0 引用数: 0 h-index: 0Herremans, Kelly M.论文数: 0 引用数: 0 h-index: 0Mukhopadhyay, Nitai论文数: 0 引用数: 0 h-index: 0Vudatha, Vignesh论文数: 0 引用数: 0 h-index: 0Raman, Shreya论文数: 0 引用数: 0 h-index: 0George, Thomas论文数: 0 引用数: 0 h-index: 0Trevino, Jose G.论文数: 0 引用数: 0 h-index: 0
- [45] Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trialsEuropean Journal of Clinical Pharmacology, 2017, 73 : 409 - 416Kerstin Breithaupt-Groegler论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyChristoph Coch论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyMartin Coenen论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyFrank Donath论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyKatharina Erb-Zohar论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyKlaus Francke论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyKarin Goehler论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyMario Iovino论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyKlaus Peter Kammerer论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyGerd Mikus论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyJens Rengelshausen论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyHildegard Sourgens论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyReinhard Schinzel论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyThomas Sudhop论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical PharmacologyGeorg Wensing论文数: 0 引用数: 0 h-index: 0机构: -kbr- clinical pharmacology services,Institute of Clinical Chemistry and Clinical Pharmacology
- [46] Finding appropriate clinical trials: Evaluating encoded eligibility criteria with incomplete dataJOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2001, : 27 - 31Ash, N论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USA Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USAOgunyemi, O论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USAZeng, Q论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USAOhno-Machado, L论文数: 0 引用数: 0 h-index: 0机构: Harvard Univ, Brigham & Womens Hosp, Sch Med, Decis Syst Grp, Boston, MA 02115 USA
- [47] Eligibility Criteria of Randomized Controlled Trials in Critical Care Medicine: A Systematic ReviewAMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209Heybati, K.论文数: 0 引用数: 0 h-index: 0机构: Mayo Clin, Alix Sch Med, Rochester, MN USA Mayo Clin, Alix Sch Med, Rochester, MN USAHeirali, A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada Mayo Clin, Alix Sch Med, Rochester, MN USASereeyotin, J.论文数: 0 引用数: 0 h-index: 0机构: Sinai Hlth Syst, Dept Med, Toronto, ON, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAKhan, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAYarnell, C. J.论文数: 0 引用数: 0 h-index: 0机构: Toronto Gen Hosp, Crit Care Med, Toronto, ON, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAKrewulak, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAMurthy, S.论文数: 0 引用数: 0 h-index: 0机构: Univ British Columbia, Vancouver, BC, Canada Mayo Clin, Alix Sch Med, Rochester, MN USABurns, K. E.论文数: 0 引用数: 0 h-index: 0机构: St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAFowler, R.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAFiest, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada Mayo Clin, Alix Sch Med, Rochester, MN USAMehta, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada Mayo Clin, Alix Sch Med, Rochester, MN USA
- [48] Who is a 'healthy subject'?-consensus results on pivotal eligibility criteria for clinical trialsEUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (04) : 409 - 416Breithaupt-Groegler, Kerstin论文数: 0 引用数: 0 h-index: 0机构: Kbr Clin Pharmacol Serv, D-60431 Frankfurt, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyCoch, Christoph论文数: 0 引用数: 0 h-index: 0机构: Univ Bonn, Inst Clin Chem & Clin Pharmacol, Sigmund Freud Str 25, D-53127 Bonn, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyCoenen, Martin论文数: 0 引用数: 0 h-index: 0机构: Univ Bonn, Inst Clin Chem & Clin Pharmacol, Sigmund Freud Str 25, D-53127 Bonn, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyDonath, Frank论文数: 0 引用数: 0 h-index: 0机构: SocraTec Res & Dev GmbH, D-99084 Erfurt, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyErb-Zohar, Katharina论文数: 0 引用数: 0 h-index: 0机构: Clinphase, D-63454 Hanau, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyFrancke, Klaus论文数: 0 引用数: 0 h-index: 0机构: Natl Assoc Statutory Hlth Insurance Funds, Med Prod Dept, D-10117 Berlin, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyGoehler, Karin论文数: 0 引用数: 0 h-index: 0机构: Gruenenthal GmbH, Gruenenthal Innovat Dev Clin Dev Clin Pharmacol, D-52099 Aachen, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyIovino, Mario论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, D-88397 Biberach, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyKammerer, Klaus Peter论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, D-88397 Biberach, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, Germany论文数: 引用数: h-index:机构:Rengelshausen, Jens论文数: 0 引用数: 0 h-index: 0机构: Gruenenthal GmbH, Gruenenthal Innovat Res Translat Sci & Strategy E, D-52078 Aachen, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanySourgens, Hildegard论文数: 0 引用数: 0 h-index: 0机构: Sourgens Consulting, D-80797 Munich, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanySchinzel, Reinhard论文数: 0 引用数: 0 h-index: 0机构: Vasopharm GmbH, D-97076 Wurzburg, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanySudhop, Thomas论文数: 0 引用数: 0 h-index: 0机构: Fed Inst Drugs & Med Devices BfArM, D-53175 Bonn, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, GermanyWensing, Georg论文数: 0 引用数: 0 h-index: 0机构: Bayer Pharma AG, Pharmaceut Div Clin Pharmacol Cardiovasc Hematol, D-42096 Wuppertal, Germany Kbr Clin Pharmacol Serv, D-60431 Frankfurt, Germany
- [49] Eligibility Criteria in Advanced Urothelial Cancer Clinical Trials: An Assessment of Modernization and InclusionCANCER MEDICINE, 2025, 14 (07):Mercier, Benjamin D.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAGovindarajan, Ameish论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USACastro, Daniela V.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USALi, Xiaochen论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAPhilip, Errol J.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAFeng, Matthew I.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAPrajapati, Sweta R.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAChan, Elyse H.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USALee, Kyle O.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USASehgal, Ishaan论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAPatel, Jalen论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAO'Dell, Anna论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAChehrazi-Raffle, Alexander论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAEbrahimi, Hedyeh论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USARock, Adam论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAZengin, Zeynep Busra论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAMeza, Luis A.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USADizman, Nazli论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAHsu, Joann论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USALiu, Sandy论文数: 0 引用数: 0 h-index: 0机构: City Hope Orange Cty Med Ctr, Dept Med Oncol, Irvine, CA USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USADorff, Tanya B.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USAPal, Sumanta K.论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USATripathi, Abhishek论文数: 0 引用数: 0 h-index: 0机构: City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA 91010 USA
- [50] AI uses patient data to optimize selection of eligibility criteria for clinical trialsNature, 2021, 592 (7855) : 512 - 513Chunhua Weng论文数: 0 引用数: 0 h-index: 0James R. Rogers论文数: 0 引用数: 0 h-index: 0